Background. Atherosclerosis is a leading cause of cardiovascular mortality worldwide, significantly impacting public health. microRNA, as key regulators of gene expression, play a crucial role in the pathogenesis of atherosclerosis, offering novel avenues for diagnostics and therapeutics. Materials and methods. A review of contemporary literature was conducted to explore the link between non-coding molecules and atherosclerosis. Data from clinical studies identifying microRNA as potential biomarkers and therapeutic targets were included. Results.The findings demonstrate that microRNA influence critical stages of atherosclerosis pathogenesis, such as inflammation, apoptosis, and lipid metabolism. Their use as diagnostic biomarkers enhances the early detection of atherosclerosis, while their therapeutic potential presents new opportunities for treatment. Conclusion. MicroRNA represent a promising tool for managing cardiovascular diseases. Further research is necessary to develop effective diagnostic and therapeutic strategies.
| Mualliflar | Юсупалиева , Д, Низамов , У, Алиева , Р, Ахмедова, Ш, Шек , А, Yusupalieva , Dilnora, Nizamov , Ulugbek, Alieva , Rano, Akhmedova, Shokhista, Shek , Aleksandr, Yusupalieva , Dilnora, Nizamov , Ulugbek, Alieva , Rano, Akhmedova, Shokhista, Shek , Aleksandr |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2024-03-30 |
| Jild | 1 |
| Son | 1 |
| Betlar | 43-50 |
| Til | Rus |
| DOI | 10.70626/cardiouz-2024-1-00006 |
DOI: 10.70626/cardiouz-2024-1-00006 · Maqolaning asl sahifasi
atherosclerosis, biomarkers, inflammation, microRNA, non-coding molecules, pathogenesis, therapeutic targets, aтеросклероз, биомаркеры, воспаление, микроРНК, некодирующие молекулы, терапевтические цели, kodlovchi bo‘lmagan molekulalar, Ateroskleroz, biomarkyerlar, mikroRNKlar, patogenez, terapevtik maqsadlar, yallig‘lanish
Arterial hypertension is a widely prevalent condition affecting millions of people worldwide. According to the World Health Organization (WHO) data, in 2021, more than 1 billion people suffered from hypertension. The…
Background. This study explores the impact of anxiety and depressive disorders on the rehabilitation outcomes and long-term prognosis of patients with acute myocardial infarction (AMI) and unstable angina. The aim is to…
Abstract. Contrast-induced nephropathy (CIN) represents a significant clinical challenge, particularly among patients diagnosed with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM). The increased…
Background. The 2023 ESC guidelines on cardiomyopathies introduce significant updates in diagnostic criteria, terminology, and treatment protocols. These guidelines aim to provide comprehensive approaches for diagnosis…
Background. Peripartum cardiomyopathy (PPCM) is a rare yet serious condition affecting women during late pregnancy or the postpartum period, often leading to complications such as ventricular arrhythmias and…
Background. Contrast-induced nephropathy (CIN) is a common complication among patients with ischemic heart disease (IHD) undergoing percutaneous coronary intervention (PCI). Understanding the pathogenesis, risk factors…
The leading cause of death worldwide is cardiovascular disease. In addition to the known factors leading to CVD, in recent years much attention has been paid to obesity as one of the components of cardiometabolic…
Background. To assess the frequency and characteristics of cardiac arrhythmias in relation to cardiac remodeling and blood prolactin levels in patients with peripartum cardiomyopathy (PPCM). Materials and methods. The…
Background. The COVID-19 pandemic has posed significant health risks, particularly for elderly patients. Studies on the impact of COVID-19 in this age group have highlighted various atypical clinical manifestations…
Background. Sodium-Glucose Cotransporter-2 (NGLT-2) inhibitors have gained significant attention for their cardioprotective properties. This review explores the cardiovascular benefits of NGLT-2 inhibitors…